Oral herpes simplex virus (HSV) disease ranges from primary herpetic gingivostomatitis to recurrent herpes labialis and intraoral recurrences. Diagnosis is usually clinical, but severe, atypical or immunocompromised presentations may need laboratory confirmation. Antivirals work best when selected and started early; antibiotics do not treat HSV.
Scope: This professional guide requires patient-specific examination and local referral, prescribing and consent standards.
Primary herpetic gingivostomatitis
Primary disease can cause fever, malaise, tender lymph nodes, diffuse painful gingivitis and multiple vesicles or ulcers across keratinised and non-keratinised mucosa. Dehydration is a major risk in children and frail adults.
Recurrent herpes labialis
Prodrome may include tingling, burning or itching followed by clustered vesicles at the lip border that crust and heal. Triggers include ultraviolet exposure, illness, trauma and stress.
Recurrent intraoral herpes
In immunocompetent patients, recurrent intraoral lesions often affect keratinised mucosa such as hard palate or attached gingiva. Non-keratinised diffuse ulcers broaden the differential.
Differential diagnosis
Consider aphthous ulceration, hand-foot-and-mouth disease, herpangina, erythema multiforme, varicella-zoster, contact reactions, trauma and autoimmune vesiculobullous disease. Unilateral dermatomal pain suggests zoster.
Testing
PCR or viral swab is useful for atypical, severe, persistent or immunocompromised cases and when diagnosis changes management. Sample a fresh vesicle/ulcer according to laboratory instructions.
Antiviral treatment
Oral acyclovir, valacyclovir or famciclovir may shorten disease when started early. Drug, dose and duration depend on primary versus recurrent infection, age, renal function, pregnancy and immune status; prescribe from current local guidance.
Supportive care
Prioritise fluids, soft diet, appropriate analgesia and lip protection. Avoid aspirin in children. Topical anaesthetics require dosing caution because swallowing and toxicity risks exist.
When to defer dental care
Defer elective treatment during active vesicular or extensive ulcerative disease when possible because manipulation can worsen pain, aerosol/contact exposure increases and clinician herpetic whitlow is a risk. Provide urgent stabilisation with enhanced planning when delay is unsafe.
Infection prevention
Standard precautions, hand hygiene, gloves, eye/face protection and environmental disinfection apply. Cover clinician hand lesions and avoid clinical duties that risk transmission according to occupational-health policy.
Red flags
Urgent medical assessment is required for eye symptoms, encephalitic signs, severe dehydration, disseminated disease, extensive eczema involvement, neonates or significant immunosuppression.
Prevention
For frequent severe recurrences, medical/dental review can consider episodic or suppressive antiviral strategies. Sunscreen lip balm may help UV-triggered disease. Avoid touching lesions and sharing items contacting saliva.
Decision table
| Question | Why it matters | Required response |
|---|---|---|
| Is the diagnosis secure? | Treatment and referral depend on cause and extent | Document differential and obtain tests or biopsy when uncertain |
| Are red flags present? | Delay may cause harm | Use an urgent specialist or medical pathway |
| Can treatment be maintained? | Hygiene, adherence and recall influence outcome | Adapt the plan and consent to realistic capacity |
| Has the condition changed? | Progression invalidates an old working diagnosis | Re-examine rather than repeat the previous intervention |
Documentation and photography
Record exact site, dimensions, surface, palpation, relevant negative findings, photographs with scale, imaging rationale, diagnosis, alternatives, consent and safety-net interval. For orthodontic care, preserve pretreatment occlusal, facial and periodontal records and the assumptions behind space management and fees.
Patient-centred communication
Use non-stigmatising language and separate confirmed findings from possibilities. Explain why observation, biopsy, referral, extraction, retention or additional costs may be recommended. Ask the patient to repeat the plan and warning signs in their own words.
Risk modification
- Stop tobacco and areca exposure and moderate alcohol where relevant.
- Control plaque, caries and periodontal inflammation before elective treatment.
- Review immune compromise, medicines, pregnancy, renal function and safeguarding needs.
- Address attendance, appliance adherence and maintenance barriers early.
Follow-up framework
Define the review date and success criteria. Compare with baseline, not memory. Escalate for non-healing, enlargement, induration, new nodes, sensory change, systemic illness, uncontrolled pain, unexpected movement or recurrent mechanical failure.
Evidence limitations
Observational studies are vulnerable to selection bias and confounding; rare-disease guidance often relies on case series. Orthodontic comparisons differ in initial malocclusion and biomechanics. Apply population evidence cautiously and avoid claiming causation from association.
Frequently asked questions
Can a photograph confirm the diagnosis?
No. It supports documentation and triage but cannot replace palpation, imaging, histopathology or longitudinal assessment when required.
Is the least invasive option always best?
The best option is the least harmful approach that can reliably diagnose, treat and be maintained. Delaying necessary biopsy or choosing unstable tooth movement is not conservative.
What if the patient declines referral or records?
Explain material risks, alternatives and warning signs, document informed refusal and provide an appropriate safety-net without abandoning urgent-care duties.
Conclusion
Good outcomes depend on early recognition, defensible planning, transparent consent and structured follow-up.
Free for members
Keep reading — it's free
The rest of this article is open to DentalReach members. Create a free account, or sign in, and every article on the site opens in full.